On April 3, LG Chem announced that it has signed an exclusive sales agreement with Mochida Pharmaceutical of Japan for the endometriosis treatment 'Dinagest' in Korea and Thailand.


LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical View original image

Dinagest is an oral progestin (progesterone) containing dienogest, which is used to treat hormone-dependent gynecological diseases such as endometriosis.


This product has demonstrated therapeutic benefits through clinical trials for adenomyosis and dysmenorrhea (menstrual pain), in addition to endometriosis, in the Japanese market for the same ingredient. It currently holds a market share of over 80% in Japan. LG Chem plans to apply for domestic sales approval next year.


Endometriosis is a condition in which endometrial tissue is present outside the uterus in the pelvic cavity and can occur at any reproductive age. The main symptoms include severe menstrual pain, lower abdominal pain, and infertility. According to the Korea Disease Control and Prevention Agency, it affects about 10–15% of women of reproductive age, and without drug treatment, the risk of recurrence is high.


Kim Sungho, Head of Specialty Care Division at LG Chem, stated, "The introduction of Dinagest marks an important starting point in expanding our existing infertility business into the broader women's health sector," adding, "We will continue to discover and develop products that provide practical support for women's health management throughout their life cycle."



Currently, LG Chem supplies a wide range of products required for in vitro fertilization procedures in Korea, from ovulation-inducing drugs such as Polytrop, IVF-M HP, and Ganirever to products related to oocyte and embryo freezing and thawing. Since last year, the company has also developed and been providing the 'Bloom' application for pregnancy preparation and infertility treatment. Starting with this endometriosis treatment, LG Chem plans to expand its women's health solutions to include medications for embryo implantation maintenance and miscarriage prevention.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing